Adam Phillip Gordon Braun (Adam Braun)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Rheumatoid Arthritis Patients

Acute Lymphoblastic Leukemia

Top Venues

Annals of hematology

Leukemia & lymphoma

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

This page only lists publications with an associated author ORCID identifier.

Publications

Adam Phillip Gordon Braun, Alex F Herrera
Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse. Leukemia & lymphoma (2024)
Adam Phillip Gordon Braun, Salman Otoukesh, Jose Tinajero, Guido Marcucci, Ibrahim Aldoss
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of hematology 103 (7) (2024)
Adam Phillip Gordon Braun, Salman Otoukesh, Jose Tinajero, Guido Marcucci, Ibrahim Aldoss
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of hematology 103 (7) (2024)
Adam Phillip Gordon Braun, Salman Otoukesh, Jose Tinajero, Guido Marcucci, Ibrahim Aldoss
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of hematology 103 (7) (2024)
Adam Phillip Gordon Braun, Salman Otoukesh, Jose Tinajero, Guido Marcucci, Ibrahim Aldoss
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL). Annals of hematology (2024)
Adam Phillip Gordon Braun, Sushanth Gouni, Astrid E Pulles, Paolo Strati, Monique C Minnema, Lihua E Budde
Bispecific Antibody Use in Patients With Lymphoma and Multiple Myeloma. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Adam Phillip Gordon Braun, Lawrence Liu, Monzr M Al Malki, Pamela S Becker
Haploidentical hematopoietic cell transplant recipient presents with late-onset Epstein Barr virus-associated posttransplant lymphoproliferative disorder. EJHaem 4 (3) (2023)